GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (OTCPK:EAPIF) » Definitions » ROE % Adjusted to Book Value

EAPIF (Euroapi) ROE % Adjusted to Book Value : -72.11% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi ROE % Adjusted to Book Value?

Euroapi's ROE % for the quarter that ended in Dec. 2024 was -20.19%. Euroapi's PB Ratio for the quarter that ended in Dec. 2024 was 0.28. Euroapi's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -72.11%.


Euroapi ROE % Adjusted to Book Value Historical Data

The historical data trend for Euroapi's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi ROE % Adjusted to Book Value Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - -0.95 -39.40 -47.86

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.97 13.12 -99.58 -19.03 -72.11

Competitive Comparison of Euroapi's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euroapi's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Euroapi's ROE % Adjusted to Book Value falls into.



Euroapi ROE % Adjusted to Book Value Calculation

Euroapi's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-13.40% / 0.28
=-47.86%

Euroapi's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-20.19% / 0.28
=-72.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroapi ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Euroapi's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.